International Forum on the Prevention of ABO Incompatible Red Blood Cell Transfusion: Summary.

IF 1.6 4区医学 Q3 HEMATOLOGY

Vox Sanguinis Pub Date : 2026-09-01 Epub Date: 2026-08-05 DOI:10.1111/vox.70326

Aline Mirrione-Savin, Michael F Murphy, Richard Schäfer, Pierre Tiberghien, Satyam Arora, Seema Dua, Markus M Mueller, Torsten Tonn, Saliou Diop, Moussa Seck, Zainab Al Fana Alarimi, Maha A Badawi, Tomohiko Sato, Aimi Miyajima, Silvano Wendel, Roberta Fachini, Tanya Petraszko, Johnathan Mack, Irene Cuppari, Daniele Prati, María Antonieta Nuñez, Edgardo Saa, Claudia S Cohn, Brian S Engel, Erica Wood, James Daly, Yanli Ji, Yang Zhao, Fanny Angelot Delettre, Veronique Bourcier, Veronica Pons, Andrea Espasa, Willem van der Merwe, Petro-Lize Wessels, Shirley Owusu-Ofori, Dilys John-Teye, Shruthi Narayan, Nicola Swarbrick, Arwa Z Al-Riyami, Nancy Dunbar

引用次数: 0

查看原文本刊更多论文

预防ABO血型不合的红细胞输血国际论坛：综述。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Vox Sanguinis 医学-血液学

CiteScore

4.40

自引率

11.10%

发文量

156

审稿时长

6-12 weeks

期刊介绍： Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections: 1) Transfusion - Transmitted Disease and its Prevention: Identification and epidemiology of infectious agents transmissible by blood; Bacterial contamination of blood components; Donor recruitment and selection methods; Pathogen inactivation. 2) Blood Component Collection and Production: Blood collection methods and devices (including apheresis); Plasma fractionation techniques and plasma derivatives; Preparation of labile blood components; Inventory management; Hematopoietic progenitor cell collection and storage; Collection and storage of tissues; Quality management and good manufacturing practice; Automation and information technology. 3) Transfusion Medicine and New Therapies: Transfusion thresholds and audits; Haemovigilance; Clinical trials regarding appropriate haemotherapy; Non-infectious adverse affects of transfusion; Therapeutic apheresis; Support of transplant patients; Gene therapy and immunotherapy. 4) Immunohaematology and Immunogenetics: Autoimmunity in haematology; Alloimmunity of blood; Pre-transfusion testing; Immunodiagnostics; Immunobiology; Complement in immunohaematology; Blood typing reagents; Genetic markers of blood cells and serum proteins: polymorphisms and function; Genetic markers and disease; Parentage testing and forensic immunohaematology. 5) Cellular Therapy: Cell-based therapies; Stem cell sources; Stem cell processing and storage; Stem cell products; Stem cell plasticity; Regenerative medicine with cells; Cellular immunotherapy; Molecular therapy; Gene therapy.